|
|
|
Volumn 114, Issue 18, 2001, Pages 3215-3216
|
|
Endogenous inhibitors of angiogenesis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTIBODY;
ANTINEOPLASTIC AGENT;
BASIC FIBROBLAST GROWTH FACTOR;
ENDOSTATIN;
VASCULOTROPIN;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CELL GROWTH;
CELL PROLIFERATION;
CONTROLLED STUDY;
DRUG TARGETING;
ENDOTHELIUM CELL;
EXTRACELLULAR MATRIX;
METASTASIS;
MITOSIS INHIBITION;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
TUMOR CELL;
TUMOR GROWTH;
TUMOR VASCULARIZATION;
VASCULAR ENDOTHELIUM;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTIBODIES;
APOPTOSIS;
ENDOTHELIAL GROWTH FACTORS;
ENDOTHELIUM, VASCULAR;
EXTRACELLULAR MATRIX;
FIBROBLAST GROWTH FACTOR 2;
HUMANS;
LYMPHOKINES;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
RECOMBINANT PROTEINS;
SIGNAL TRANSDUCTION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 0034772620
PISSN: 00219533
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (18)
|
|
References (3)
|
